Glenmark Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE935A01035
  • NSEID: GLENMARK
  • BSEID: 532296
INR
2,449.80
9.8 (0.4%)
BSENSE

Aug 27, 01:26 PM

BSE+NSE Vol: 3.3 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
28.22
28.22
28.22
28.22
28.22
28.22
Share Warrants & Outstandings
Total Reserve
10,483.89
8,821.22
7,819.71
9,445.71
9,058.43
7,036.41
Shareholder's Funds
10,512.11
8,849.44
7,847.93
9,473.92
9,086.65
7,064.63
Minority Interest
-0.32
-0.37
-0.38
365.34
351.47
-0.35
Long-Term Borrowings
0.00
512.70
0.00
3,997.72
3,300.35
3,888.82
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
512.70
0.00
3,997.72
3,300.35
3,888.82
Deferred Tax Assets / Liabilities
-1,245.38
-1,065.52
-1,049.44
-1,805.40
-1,654.63
-1,505.92
Other Long Term Liabilities
2841.81
662.17
692.21
574.71
352.5
420.72
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
176.61
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
1,773.05
109.35
-357.23
2,621.45
1,269.61
2,803.62
Current Liabilities
Trade Payables
3,743.87
3,051.20
2,535.93
2,000.43
2,288.66
2,237.77
Other Current Liabilities
1,562.46
464.54
1,650.94
2,117.04
810.78
650.31
Short Term Borrowings
0.00
1,681.49
990.60
495.58
1,098.61
798.61
Short Term Provisions
1,070.09
769.79
641.12
492.01
491.38
514.33
Total Current Liabilities
6,376.43
5,967.02
5,818.59
5,105.06
4,689.43
4,201.02
Total Liabilities
18,661.26
14,925.44
13,308.90
17,565.76
15,397.17
14,068.91
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
11,194.10
9,719.92
9,026.27
9,820.58
9,725.06
8,304.81
Less: Accumulated Depreciation
5,825.02
5,476.31
5,015.19
4,615.39
4,086.88
3,441.14
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
5,369.09
4,243.62
4,011.09
5,205.19
5,638.18
4,863.67
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
427.87
541.99
419.32
1,065.82
921.09
1,217.79
Intangible assets under development
481.26
292.84
242.56
123.81
88.78
163.88
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
42.36
56.35
789.66
44.57
49.62
24.62
Long Term Loans & Advances
492.67
242.74
211.70
180.80
161.38
146.29
Other Non Current Assets
2.86
9.23
7.42
3.46
6.70
27.89
Total Non-Current Assets
7,361.56
5,629.98
5,880.82
6,840.24
7,114.82
6,709.33
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
3,430.78
3,028.53
2,513.05
2,373.62
2,499.83
2,276.83
Sundry Debtors
4,963.35
3,341.95
1,858.41
3,665.17
3,101.14
2,572.05
Cash and Bank
1,176.26
1,705.23
1,659.46
1,160.30
1,411.52
1,139.16
Other Current Assets
308.42
144.97
178.21
2,618.50
297.46
324.60
Short Term Loans and Advances
1,420.90
1,074.79
1,218.95
907.93
972.41
1,046.93
Total Current Assets
11,299.71
9,295.47
7,428.08
10,725.53
8,282.35
7,359.58
Net Current Assets (Including Current Investments)
4,923.28
3,328.44
1,609.49
5,620.47
3,592.92
3,158.56
Total Current Assets Excluding Current Investments
11,299.71
9,295.47
7,428.08
10,725.53
8,282.35
7,359.58
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
18,661.26
14,925.44
13,308.90
17,565.76
15,397.17
14,068.91
Contingent Liabilities
787.81
800.26
1,063.30
336.69
361.31
384.20
Total Debt
0.00
2,194.20
990.60
4,202.14
2,941.74
4,687.43
Book Value per share (adjusted)
372.51
313.6
278.11
335.75
322.03
250.37
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is -100.00% vs 121.50% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 329.17% vs -4.34% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 21.13% vs 8.02% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is -24.83% vs -92.86% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 21.56% vs 25.14% in Mar 2025

Compare Balance Sheet Results of Glenmark Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
28.22
58.08
-29.86
-51.41%
Share Warrants & Outstandings
Total Reserve
10,483.89
37,832.89
-27,349.00
-72.29%
Shareholder's Funds
10,512.11
37,890.97
-27,378.86
-72.26%
Minority Interest
-0.32
-8.16
7.84
96.08%
Long-Term Borrowings
0.00
802.75
-802.75
-100.00%
Secured Loans
0.00
798.20
-798.20
-100.00%
Unsecured Loans
0.00
4.55
-4.55
-100.00%
Deferred Tax Assets / Liabilities
-1,245.38
-1,177.59
-67.79
-5.76%
Other Long Term Liabilities
2,841.81
1,071.17
1,770.64
165.30%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
176.61
400.41
-223.80
-55.89%
Total Non-Current Liabilities
1,773.05
1,096.74
676.31
61.67%
Current Liabilities
Trade Payables
3,743.87
5,567.27
-1,823.40
-32.75%
Other Current Liabilities
1,562.46
5,245.25
-3,682.79
-70.21%
Short Term Borrowings
0.00
6,873.45
-6,873.45
-100.00%
Short Term Provisions
1,070.09
353.04
717.05
203.11%
Total Current Liabilities
6,376.43
18,039.01
-11,662.58
-64.65%
Total Liabilities
18,661.26
57,018.56
-38,357.30
-67.27%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
11,194.10
28,675.10
-17,481.00
-60.96%
Less: Accumulated Depreciation
5,825.02
11,643.25
-5,818.23
-49.97%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5,369.09
17,031.85
-11,662.76
-68.48%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
427.87
3,008.83
-2,580.96
-85.78%
Intangible assets under development
481.26
2,204.73
-1,723.47
-78.17%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
42.36
303.88
-261.52
-86.06%
Long Term Loans & Advances
492.67
971.58
-478.91
-49.29%
Other Non Current Assets
2.86
414.21
-411.35
-99.31%
Total Non-Current Assets
7,361.56
24,309.81
-16,948.25
-69.72%
Current Assets Loans & Advances
Current Investments
0.00
747.24
-747.24
-100.00%
Inventories
3,430.78
12,052.94
-8,622.16
-71.54%
Sundry Debtors
4,963.35
7,094.37
-2,131.02
-30.04%
Cash and Bank
1,176.26
9,870.29
-8,694.03
-88.08%
Other Current Assets
308.42
362.98
-54.56
-15.03%
Short Term Loans and Advances
1,420.90
2,580.93
-1,160.03
-44.95%
Total Current Assets
11,299.71
32,708.75
-21,409.04
-65.45%
Net Current Assets (Including Current Investments)
4,923.28
14,669.74
-9,746.46
-66.44%
Total Current Assets Excluding Current Investments
11,299.71
31,961.51
-20,661.80
-64.65%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
18,661.26
57,018.56
-38,357.30
-67.27%
Contingent Liabilities
787.81
834.37
-46.56
-5.58%
Total Debt
0.00
7,676.20
-7,676.20
-100.00%
Book Value per share (adjusted)
372.51
652.39
-279.88
-42.90%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -100.00% vs 121.50% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 2,841.81 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 329.17% vs -4.34% in Mar 2025

Annual - Fixed Assets
Fixed Assets 5,796.96 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 21.13% vs 8.02% in Mar 2025

Annual - Investments
Investments 42.36 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -24.83% vs -92.86% in Mar 2025

Annual - Current Assets
Current Assets 11,299.71 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 21.56% vs 25.14% in Mar 2025